DINO J DELAPORTAS
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease
- Where
- BRIDGEPORT, WV
- NPI
- 1639124159
- Received
- $478,093 in 966 records, 2019 to 2025
- As principal investigator
- $261,670 of research payments to others in 51 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 46 | $12,198 |
| 2024 | General payment | 43 | $13,071 |
| 2023 | General payment | 85 | $47,748 |
| 2022 | General payment | 212 | $122,634 |
| 2021 | General payment | 104 | $42,228 |
| 2020 | General payment | 106 | $35,263 |
| 2019 | General payment | 370 | $204,949 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 205 | $312,543 |
| Travel and Lodging | 242 | $113,631 |
| Food and Beverage | 486 | $21,076 |
| Honoraria | 7 | $12,665 |
| Consulting Fee | 12 | $11,663 |
| Compensation for serving as faculty or as a speaker for a medical education program | 3 | $5,000 |
| Education | 11 | $1,512 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-15 | Cumberland Pharmaceuticals, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-12-12 | Paratek Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-12-06 | Cumberland Pharmaceuticals, Inc. | $194 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-12-06 | Cumberland Pharmaceuticals, Inc. | $33 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-12-04 | Melinta Therapeutics, LLC | $1,950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2025 | |
| 2025-12-04 | Melinta Therapeutics, LLC | $20 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2025 | |
| 2025-11-26 | Organogenesis Inc. | $16 | Food and Beverage | In-kind items and services | NUSHIELD Medical Supply, WOUND CARE | 2025 | |
| 2025-11-24 | Cumberland Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-11-19 | Paratek Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-11-05 | Cumberland Pharmaceuticals, Inc. | $64 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-11-03 | Paratek Pharmaceuticals, Inc. | $9 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-10-29 | Cumberland Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-10-29 | Melinta Therapeutics, LLC | $15 | Food and Beverage | In-kind items and services | Rezzayo Drug, ANTIFUNGALS | 2025 | |
| 2025-10-21 | Paratek Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-09-25 | Cumberland Pharmaceuticals, Inc. | $2,580 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-09-24 | Cumberland Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-09-23 | Paratek Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-09-12 | Cumberland Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-09-09 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-09-02 | Paratek Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-08-26 | Organogenesis Inc. | $26 | Food and Beverage | In-kind items and services | CYGNUS MATRIX Medical Supply, WOUND CARE | 2025 | |
| 2025-08-18 | Paratek Pharmaceuticals, Inc. | $10 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-08-14 | Melinta Therapeutics, LLC | $12 | Food and Beverage | In-kind items and services | Rezzayo Drug, ANTIFUNGALS | 2025 | |
| 2025-08-14 | Melinta Therapeutics, LLC | $6 | Food and Beverage | In-kind items and services | Rezzayo Drug, ANTIFUNGALS | 2025 | |
| 2025-08-08 | Cumberland Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-07-25 | Ferring Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2025 | |
| 2025-07-18 | Insmed, Inc. | $20 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-07-15 | Organogenesis Inc. | $29 | Food and Beverage | In-kind items and services | PURAPLY WOUND MATRIX Device, WOUND CARE | 2025 | |
| 2025-06-27 | Cumberland Pharmaceuticals, Inc. | $11 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-06-24 | Paratek Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-06-05 | Melinta Therapeutics, LLC | $20 | Food and Beverage | In-kind items and services | Rezzayo Drug, ANTIFUNGALS | 2025 | |
| 2025-06-02 | Paratek Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-05-29 | Merck Sharp & Dohme LLC | $125 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-05-28 | Smith+Nephew, Inc. | $24 | Food and Beverage | In-kind items and services | COLLAGENASE SANTYL Drug, Pharma Products | 2025 | |
| 2025-05-06 | Cumberland Pharmaceuticals, Inc. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-04-28 | Paratek Pharmaceuticals, Inc. | $11 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-04-25 | Melinta Therapeutics, LLC | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2025 | |
| 2025-04-17 | Melinta Therapeutics, LLC | $850 | Travel and Lodging | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2025 | |
| 2025-04-17 | Melinta Therapeutics, LLC | $87 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2025 | |
| 2025-04-08 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-04-04 | Cumberland Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2025 | |
| 2025-04-04 | Melinta Therapeutics, LLC | $14 | Food and Beverage | In-kind items and services | Rezzayo Drug, ANTIFUNGALS | 2025 | |
| 2025-03-20 | Organogenesis Inc. | $28 | Food and Beverage | In-kind items and services | CYGNUS DUAL Medical Supply, WOUND CARE | 2025 | |
| 2025-01-28 | Shionogi Inc | $95 | Food and Beverage | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2025 | |
| 2025-01-15 | Smith+Nephew, Inc. | $41 | Food and Beverage | In-kind items and services | COLLAGENASE SANTYL Drug, Pharma Products | 2025 | |
| 2025-01-11 | Insmed, Inc. | $29 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2024-12-05 | Paratek Pharmaceuticals, Inc. | $77 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-11-20 | Melinta Therapeutics, LLC | $21 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-11-13 | Paratek Pharmaceuticals, Inc. | $10 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-11-08 | Insmed, Inc. | $26 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2024 | |
| 2024-11-05 | Cumberland Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2024 | |
| 2024-11-04 | Paratek Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-10-25 | Organogenesis Inc. | $22 | Food and Beverage | In-kind items and services | APLIGRAF Device, WOUND CARE | 2024 | |
| 2024-10-22 | Paratek Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-10-18 | Invivyd Inc | $22 | Food and Beverage | In-kind items and services | PEMGARDA Biological, INFECTIOUS DISEASE | 2024 | |
| 2024-09-23 | Cumberland Pharmaceuticals, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2024 | |
| 2024-09-12 | Cumberland Pharmaceuticals, Inc. | $154 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2024 | |
| 2024-09-09 | Paratek Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-08-27 | Reprise Biomedical, Inc. | $22 | Food and Beverage | In-kind items and services | Miro3D Device, Wound Dressing | 2024 | |
| 2024-08-23 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | GARDASIL Biological, VACCINE | 2024 | |
| 2024-08-22 | Melinta Therapeutics, LLC | $1,950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-08-22 | Melinta Therapeutics, LLC | $106 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-08-19 | Paratek Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-08-08 | Organogenesis Inc. | $19 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-22 | Paratek Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-07-19 | Insmed, Inc. | $23 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2024 | |
| 2024-07-18 | La Jolla Pharmaceutical Company | $27 | Food and Beverage | In-kind items and services | XACDURO Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-07-16 | Cumberland Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2024 | |
| 2024-07-01 | Paratek Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-06-21 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-06-20 | Melinta Therapeutics, LLC | $19 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-06-03 | Paratek Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-05-21 | Ferring Pharmaceuticals Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2024 | |
| 2024-05-17 | Cumberland Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2024 | |
| 2024-05-15 | Ferring Pharmaceuticals Inc. | $395 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2024 | |
| 2024-05-15 | Ferring Pharmaceuticals Inc. | $115 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2024 | |
| 2024-05-06 | Paratek Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2024 | |
| 2024-04-26 | Shionogi Inc | $30 | Food and Beverage | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-04-15 | Cumberland Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2024 | |
| 2024-04-09 | La Jolla Pharmaceutical Company | $25 | Food and Beverage | In-kind items and services | XERAVA Drug, TETRACYCLINE CLASS ANTIBACTERIAL | 2024 | |
| 2024-04-02 | Merck Sharp & Dohme LLC | $24 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-03-08 | Insmed, Inc. | $15 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2024 | |
| 2024-02-27 | Melinta Therapeutics, LLC | $18 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-02-08 | Melinta Therapeutics, LLC | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-02-08 | Melinta Therapeutics, LLC | $1,387 | Travel and Lodging | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-02-08 | Melinta Therapeutics, LLC | $55 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-02-02 | Cumberland Pharmaceuticals, Inc. | $825 | Consulting Fee | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2024 | |
| 2024-01-24 | Melinta Therapeutics, LLC | $100 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2024 | |
| 2024-01-16 | LifeNet Health | $23 | Food and Beverage | Cash or cash equivalent | TheraGenesis Wound Matrix Device, Wound | 2024 | |
| 2023-12-21 | LifeNet Health | $24 | Food and Beverage | Cash or cash equivalent | TheraGenesis Wound Matrix Device, Wound | 2023 | |
| 2023-12-12 | Cumberland Pharmaceuticals, Inc. | $2 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-11-10 | Cumberland Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | CALDOLOR Drug, ANESTHESIOLOGY PAIN MANAGEMENT | 2023 | |
| 2023-11-08 | LifeNet Health | $20 | Food and Beverage | Cash or cash equivalent | TheraGenesis Wound Matrix Device, Wound | 2023 | |
| 2023-11-01 | Melinta Therapeutics, LLC | $15 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2023 | |
| 2023-10-31 | Cumberland Pharmaceuticals, Inc. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-10-25 | Cumberland Pharmaceuticals, Inc. | $11 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-09-21 | NESTLE HEALTHCARE NUTRITION INC. | $16 | Education | In-kind items and services | VOWST Biological, GI | 2023 | |
| 2023-09-12 | Ferring Pharmaceuticals Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-09-02 | Insmed, Inc. | $23 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2023 | |
| 2023-08-30 | Ferring Pharmaceuticals Inc. | $580 | Education | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-08-25 | LifeNet Health | $22 | Food and Beverage | Cash or cash equivalent | TheraGenesis Wound Matrix Device, Wound | 2023 | |
| 2023-08-22 | Ferring Pharmaceuticals Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-08-09 | Melinta Therapeutics, LLC | $18 | Food and Beverage | In-kind items and services | Rezzayo Drug, ANTIFUNGALS | 2023 | |
| 2023-08-03 | Insmed, Inc. | $325 | Consulting Fee | Cash or cash equivalent | Arikayce Drug, Respiratory | 2023 | |
| 2023-08-01 | Smith+Nephew, Inc. | $14 | Food and Beverage | In-kind items and services | COLLAGENASE SANTYL Drug, Pharma Products | 2023 | |
| 2023-07-19 | Cumberland Pharmaceuticals, Inc. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-07-19 | Ferring Pharmaceuticals Inc. | $1,384 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-07-19 | Ferring Pharmaceuticals Inc. | $159 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-07-12 | Cumberland Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-07-11 | Smith+Nephew, Inc. | $15 | Food and Beverage | In-kind items and services | COLLAGENASE SANTYL Drug, Pharma Products | 2023 | |
| 2023-06-20 | Ferring Pharmaceuticals Inc. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-06-13 | LifeNet Health | $21 | Food and Beverage | Cash or cash equivalent | TheraGenesis Wound Matrix Device, Wound | 2023 | |
| 2023-06-06 | Cumberland Pharmaceuticals, Inc. | $10 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-06-06 | Cumberland Pharmaceuticals, Inc. | $2 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-06-06 | Cumberland Pharmaceuticals, Inc. | $0 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-05-31 | Cumberland Pharmaceuticals, Inc. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-05-25 | Melinta Therapeutics, LLC | $1,950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2023 | |
| 2023-05-25 | Melinta Therapeutics, LLC | $948 | Travel and Lodging | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2023 | |
| 2023-05-25 | Melinta Therapeutics, LLC | $108 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2023 | |
| 2023-05-24 | Cumberland Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-05-24 | Cumberland Pharmaceuticals, Inc. | $0 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-05-23 | Insmed, Inc. | $75 | Education | In-kind items and services | Arikayce Drug, Respiratory | 2023 | |
| 2023-05-23 | Insmed, Inc. | $13 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2023 | |
| 2023-05-09 | Ferring Pharmaceuticals Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-05-09 | Ferring Pharmaceuticals Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-04-26 | Ferring Pharmaceuticals Inc. | $1,228 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-04-26 | Ferring Pharmaceuticals Inc. | $125 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-04-26 | Smith+Nephew, Inc. | $12 | Food and Beverage | In-kind items and services | REGRANEX Drug, Pharma Products | 2023 | |
| 2023-04-20 | Ferring Pharmaceuticals Inc. | $1,181 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-04-20 | Ferring Pharmaceuticals Inc. | $62 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-04-18 | Bioventus LLC | $23 | Food and Beverage | In-kind items and services | SonicOne Clinic Device, Devices | 2023 | |
| 2023-04-13 | Melinta Therapeutics, LLC | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Kimyrsa Drug, ANTIBIOTICS | 2023 | |
| 2023-04-13 | Melinta Therapeutics, LLC | $118 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2023 | |
| 2023-04-12 | Smith+Nephew, Inc. | $14 | Food and Beverage | In-kind items and services | REGRANEX Drug, Pharma Products | 2023 | |
| 2023-04-11 | Cumberland Pharmaceuticals, Inc. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2023-04-04 | Ferring Pharmaceuticals Inc. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-04-04 | Ferring Pharmaceuticals Inc. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-04-04 | Insmed, Inc. | $650 | Consulting Fee | Cash or cash equivalent | Arikayce Drug, Respiratory | 2023 | |
| 2023-03-29 | Ferring Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-16 | Ferring Pharmaceuticals Inc. | $430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-15 | Ferring Pharmaceuticals Inc. | $766 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-15 | Ferring Pharmaceuticals Inc. | $458 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-15 | Ferring Pharmaceuticals Inc. | $163 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-15 | Ferring Pharmaceuticals Inc. | $99 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-15 | Ferring Pharmaceuticals Inc. | $13 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-14 | Ferring Pharmaceuticals Inc. | $4,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-10 | Ferring Pharmaceuticals Inc. | $452 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-10 | Ferring Pharmaceuticals Inc. | $383 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-09 | Ferring Pharmaceuticals Inc. | $686 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-09 | Ferring Pharmaceuticals Inc. | $383 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-09 | Ferring Pharmaceuticals Inc. | $224 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-09 | Ferring Pharmaceuticals Inc. | $120 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-09 | Ferring Pharmaceuticals Inc. | $14 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-09 | Ferring Pharmaceuticals Inc. | $13 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-03-01 | Insmed, Inc. | $325 | Consulting Fee | Cash or cash equivalent | Arikayce Drug, Respiratory | 2023 | |
| 2023-02-21 | Ferring Pharmaceuticals Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-17 | Insmed, Inc. | $15 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2023 | |
| 2023-02-14 | Ferring Pharmaceuticals Inc. | $580 | Education | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-07 | Ferring Pharmaceuticals Inc. | $1,406 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-07 | Ferring Pharmaceuticals Inc. | $105 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-04 | Ferring Pharmaceuticals Inc. | $142 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-04 | Ferring Pharmaceuticals Inc. | $105 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-04 | Ferring Pharmaceuticals Inc. | $54 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-03 | Ferring Pharmaceuticals Inc. | $383 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-03 | Ferring Pharmaceuticals Inc. | $218 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-03 | Ferring Pharmaceuticals Inc. | $156 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-03 | Ferring Pharmaceuticals Inc. | $136 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-03 | Ferring Pharmaceuticals Inc. | $87 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-02 | Ferring Pharmaceuticals Inc. | $374 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-02 | Ferring Pharmaceuticals Inc. | $174 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-02-02 | Ferring Pharmaceuticals Inc. | $57 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-01-27 | Melinta Therapeutics, LLC | $13 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2023 | |
| 2023-01-26 | Ferring Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | REBYOTA Biological, GASTROENTEROLOGY | 2023 | |
| 2023-01-13 | Cumberland Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | VIBATIV Drug, INFECTIONS AND INFECTIOUS DISEASES | 2023 | |
| 2022-12-27 | Ferring Pharmaceuticals Inc. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-12-27 | Ferring Pharmaceuticals Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-12-21 | Ferring Pharmaceuticals Inc. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-12-13 | Melinta Therapeutics, LLC | $77 | Food and Beverage | In-kind items and services | Kimyrsa Drug, ANTIBIOTICS | 2022 | |
| 2022-12-01 | Ferring Pharmaceuticals Inc. | $565 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-12-01 | Ferring Pharmaceuticals Inc. | $565 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-12-01 | Ferring Pharmaceuticals Inc. | $107 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-30 | Ferring Pharmaceuticals Inc. | $42 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-30 | Ferring Pharmaceuticals Inc. | $10 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $436 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $322 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $256 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $256 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $137 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $90 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $35 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-29 | Ferring Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-28 | Ferring Pharmaceuticals Inc. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-11-28 | Ferring Pharmaceuticals Inc. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-11-28 | Ferring Pharmaceuticals Inc. | $2,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-11-28 | Ferring Pharmaceuticals Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-11-28 | Ferring Pharmaceuticals Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-11-28 | Ferring Pharmaceuticals Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-11-18 | Ferring Pharmaceuticals Inc. | $137 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-18 | Ferring Pharmaceuticals Inc. | $32 | Travel and Lodging | In-kind items and services | 2022 | ||
| 2022-11-18 | Organogenesis Inc. | $23 | Food and Beverage | Cash or cash equivalent | Puraply Medical Supply, WOUND CARE | 2022 |
The latest 200 records of 966.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-09-17 | Janssen Research & Development, LLC | Ima Evaluations Llc | $11,931 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2025-09-17 | Janssen Research & Development, LLC | Ima Evaluations Llc | $3,000 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2025-08-26 | Janssen Research & Development, LLC | Ima Evaluations Llc | $858 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2025-04-17 | Janssen Research & Development, LLC | Ima Evaluations Llc | $2,610 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2025-03-25 | Janssen Research & Development, LLC | Ima Evaluations Llc | $286 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2025-02-19 | Janssen Research & Development, LLC | Ima Evaluations Llc | $572 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2025-01-21 | Janssen Research & Development, LLC | Ima Evaluations Llc | $429 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2025-01-13 | Janssen Research & Development, LLC | Ima Evaluations Llc | $40 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2025 |
| 2024-12-20 | Janssen Research & Development, LLC | Ima Evaluations Llc | $286 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-11-21 | Janssen Research & Development, LLC | Ima Evaluations Llc | $2,002 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-11-20 | Janssen Research & Development, LLC | Ima Evaluations Llc | $46,330 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-10-16 | Janssen Research & Development, LLC | Ima Evaluations Llc | $40 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-10-15 | Janssen Research & Development, LLC | Ima Evaluations Llc | $429 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-09-13 | Janssen Research & Development, LLC | Ima Evaluations Llc | $1,144 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-07-29 | Janssen Research & Development, LLC | Ima Evaluations Llc | $143 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-05-21 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $143 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-05-16 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $40 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-04-17 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $286 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-04-15 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $40 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-04-08 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $572 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-02-29 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $572 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2024-01-18 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $715 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2024 |
| 2023-12-21 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $286 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-12-11 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $40 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-11-28 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $2,431 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-11-07 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $572 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-09-29 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $1,001 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-09-12 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $21,424 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-09-07 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $243 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-09-07 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $100 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-08-31 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $3,421 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-07-03 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $3,740 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-05-30 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $3,484 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-04-21 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $4,200 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-03-23 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $5,058 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-03-01 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $2,040 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-02-17 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $1,750 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2023-01-31 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $878 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2023 |
| 2022-12-16 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $3,354 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-11-21 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $42,751 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-11-15 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $8,000 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-11-15 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $619 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-11-15 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $100 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-09-23 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $100 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-09-16 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $100 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-05-16 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $2,482 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-04-11 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $5,810 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-03-14 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $2,469 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2022-03-07 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $64,749 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2022 |
| 2021-09-20 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $2,500 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2021 |
| 2021-09-20 | Janssen Research & Development, LLC | Exemplar Medcl Group Allrgy | $5,500 | A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Inv | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bridgeport, WV, county Harrison County, WV, state West Virginia; placed by its city name.
| Measure | Place (city or town) Bridgeport, WV | County Harrison County, WV | State West Virginia |
|---|---|---|---|
| Population B01003 | 9,252 | 64,984 | 1,778,373 |
| Population, 2020 census P1 | 9,336 | 65,921 | 1,793,716 |
| Median age B01002 | 45.6 | 42.6 | 42.7 |
| Under 18 B01001 | 16.3% | 21.2% | 20.0% |
| 65 and over B01001 | 23.5% | 20.3% | 21.0% |
| Households B11001 | 4,099 | 26,353 | 728,655 |
| Foreign born B05002 | 3.9% | 1.2% | 1.8% |
| Median household income B19013 | $100,022 | $60,377 | $59,608 |
| Median family income B19113 | $135,266 | $81,873 | $77,710 |
| Per capita income B19301 | $55,374 | $35,791 | $34,203 |
| Poverty rate B17001 | 3.9% | 14.4% | 16.7% |
| Unemployment rate B23025 | 2.3% | 4.0% | 5.4% |
| Civilian labor force B23025 | 4,863 | 29,605 | 786,889 |
| Mean commute (minutes) B08013 | 18.9 | 22.4 | 26.6 |
| Bachelor's degree or higher B15003 | 53.4% | 27.2% | 24.1% |
| Housing units B25001 | 4,413 | 30,537 | 861,325 |
| Owner-occupied B25003 | 75.5% | 73.6% | 74.9% |
| Renters B25003 | 24.5% | 26.4% | 25.1% |
| Median home value B25077 | $291,600 | $166,200 | $162,600 |
| Median gross rent B25064 | $1,105 | $879 | $872 |
| White, not Hispanic B03002 | 88.5% | 91.8% | 89.7% |
| Black B03002 | 1.9% | 1.5% | 3.1% |
| Hispanic or Latino B03002 | 4.3% | 2.3% | 2.1% |
| Asian B03002 | 3.8% | 0.8% | 0.8% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bridgeport, WV.
Comments